Embecta Corp. announced its earnings for the quarter that ended in June 2024. They earned 74 cents for each share, which is more than what people expected (48 cents per share). This is good news for the company, as it shows they are making more money than thought. The stock price has gone down a lot this year, but the company's earnings are still better than what most other companies in the same industry are doing. Read from source...

Neutral
### Final comments:
- The article is a business report about Embecta Corp.'s earnings
- The article contains earnings estimates and comparisons, as well as industry rank and outlook
- The article also mentions another company in the same industry, HealthEquity, and its upcoming earnings report
- The article ends with a promotion for Benzinga's Fintech newsletter

### Summary:
The article is a factual report about Embecta Corp.'s earnings and outlook, and how they compare to the industry and analyst expectations. It also provides some information about another company in the same industry, HealthEquity, and its upcoming earnings report. The article ends with a promotion for Benzinga's Fintech newsletter.

### Relevant knowledge:
- Embecta Corp. is a medical services company that provides diagnostic testing and other health care services
- The company reported quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.48 per share, and revenues of $272.5 million, surpassing the Zacks Consensus Estimate by 0.74%
- The company has beat consensus EPS estimates four times in the last four quarters, but has underperformed the market and its industry in terms of stock price performance
- The company has a Zacks Rank of #3 (Hold), which means that it is expected to perform in line with the market in the near future
- The company's earnings estimate revisions trend has been mixed, which means that the expectations for the coming quarters and current fiscal year have not changed significantly
- HealthEquity is another company in the same industry, but it has not reported its earnings yet, and its earnings estimates have remained unchanged over the last 30 days